Over the course of more than 25 years as a patent attorney matched with in-house experience as a pharmaceutical chemist at DuPont Merck Pharmaceuticals and Smithkline Beecham, Allen Baum, partner-in-charge of the Raleigh office, has the ability to take complex scientific and legal issues and distill them into timely, relevant and useful counsel.
Clients hire Allen to identify and execute strategies to protect key commercial products and bring lucrative products to market in areas heavily patented by competitors. With an extensive litigation background, he is also frequently retained to evaluate the strength of patents under consideration for licensing, acquisition or investment.
Allen frequently assist clients with strategies for pursuing commercially significant patent portfolios and has managed large portfolios of patent applications for Global Fortune 100 companies. He has also provided opinions on patents protecting products with sales in excess of $1 billion. His representative clients are active in small molecule pharmaceuticals, biotechnology, biochemistry, vaccines, medical devices, ocular medications and implants, green technologies, and advanced materials.
Allen’s work includes post grant litigation and inter partes review before the U.S. Patent and Trademark Office, freedom-to-operate studies, due diligence review, infringement and validity studies, licensing, Hatch-Waxman litigation, reexamination, and patent preparation and prosecution in the areas of chemistry, pharmaceuticals, biochemistry, biotechnology, and medical devices.
Active in leadership roles in the IP industry, Allen is a former president of the Licensing Executives Society for the USA and Canada, a former president of the Board of Governor’s for Certified Licensing Professionals (CLP), and was managing partner of his prior firm’s Research Triangle Park office and served on its board of directors for four years. He is also a frequent instructor for intellectual asset management courses and a frequent speaker on life sciences IP topics.
Professional and Community Involvement
Instructor, Licensing Executives Society on the Fundamentals and Intermediate Intellectual Asset Management Series
Former president, Licensing Executives Society for USA and Canada
Former president and board of governors chair, Certified Licensing Professionals (CLP)
Member, American Bar Association
Member, American Intellectual Property Law Association
Member, Licensing Executives Society
Member, Triangle Intellectual Property Law Association
LMG Life Sciences Life Science Star, 2018
Managing Intellectual Property, IP Star, 2013-2018
The Best Lawyers in America, 2005-2020; Lawyer of the Year, 2018
Legal 500, Recommended Lawyer, 2017
Intellectual Asset Management, IAM Patent 1000: The World’s Leading Patent Practitioners, 2012-2018
Intellectual Asset Management, IAM 300: A Guide to the World's Leading IP Strategists, 2014
Intellectual Asset Management, IAM 250: The World’s Leading Patent & Technology Licensing Lawyers, 2010-2012
Intellectual Asset Management, IAM 250: A Guide to the World's Leading IP Strategists, 2009-2011